EP3504327
ENGINEERED TARGET SPECIFIC NUCLEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.8.2017EP published:
6.10.2021EP application number:
17844412.1
EPO information:
European Patent Register
Max expiry date:
23.8.2037
Title:
ENGINEERED TARGET SPECIFIC NUCLEASES
Timeline
Today
24.8.2017EP application
6.10.2021EP Publication
Owner
Name:
Sangamo Therapeutics, Inc.Address:
7000 Marina Blvd, Brisbane, CA 94005, US
Inventor
Name:
MILLER, Jeffrey C.Address:
Brisbane, CA 94005, US
Name:
REBAR, Edward J.Address:
Brisbane, CA 94005, US
Priority
Number:
201662378978 PDate:
24.8.2016Country:
US
Number:
201762443981 PDate:
9.1.2017Country:
US
Classification
Categories:
C12N 9/22, A61K 38/00